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Abstract 
Objective 
The study aimed to explore premorbid academic and social functioning in patients with 
schizophrenia, and its associations with the severity of negative symptoms and 
neurocognitive impairment. 
Method 
Premorbid adjustment (PA) in patients with schizophrenia was compared to early adjustment 
in unaffected first‐degree relatives and healthy controls. Its associations with 
psychopathology, cognition, and real‐life functioning were investigated. The associations of 
PA with primary negative symptoms and their two factors were explored. 
Results 
We found an impairment of academic and social PA in patients (P ≤ 0.000001) and an 
impairment of academic aspects of early adjustment in relatives (P ≤ 0.01). Patients with poor 
PA showed greater severity of negative symptoms (limited to avolition after excluding the 
effect of depression/parkinsonism), working memory, social cognition, and real‐life 
functioning (P ≤ 0.01 to ≤0.000001). Worse academic and social PA were associated with 
greater severity of psychopathology, cognitive impairment, and real‐life functioning 
impairment (P ≤ 0.000001). Regression analyses showed that worse PA in the academic 
domain was mainly associated to the impairment of working memory, whereas worse PA in 
the social domain to avolition (P ≤ 0.000001). 
Conclusion 
Our findings suggest that poor early adjustment may represent a marker of vulnerability to 
schizophrenia and highlight the need for preventive/early interventions based on 
psychosocial and/or cognitive programs. 
 
 
 Introduction 
In line with the neurodevelopmental hypothesis of schizophrenia, a poor premorbid 
adjustment has been widely reported in individuals affected by the disorder 1-3. Moreover, an 
impairment of functioning in early epochs of life has been described in unaffected relatives of 
patients with schizophrenia as compared to healthy controls 4-8. 
A worse premorbid adjustment in patients with schizophrenia is associated with severity of 
negative symptoms, neurocognitive impairment, and poor functional outcome 8-13. To 
further characterize these associations, several studies explored them by taking into account 
the distinction of premorbid functioning in two separate subdomains (i.e. the academic and 
the social one) and/or in different patterns of progression over time (i.e. ‘stable‐poor’, 
‘deteriorating’, and ‘stable‐good’); however, findings in this regard are not consistent across 
studies, as summarized below. 
The severity of negative symptoms has been associated either with the social subdomain 
only 8, 10, 14-20 or with both academic and social aspects of premorbid functioning 21-25. 
Moreover, some studies reported an association of negative symptoms with specific patterns 
of progression of premorbid adjustment over time, mainly the ‘stable‐poor’ and/or the 
‘deteriorating’ one 10, 15, 26; a lack of specificity has also been reported 27. 
Heterogeneity in findings on the association between premorbid adjustment and negative 
symptoms may be due, at least in part, to the lack of distinction between primary 
(etiologically related to the core pathophysiology of the syndrome) and secondary negative 
symptoms, that was taken into account in few studies so far 8, 19, 25, 27, 28. Furthermore, 
according to recent literature, negative symptoms include at least two factors, avolition and 
poor emotional expression, that might be underpinned by different pathophysiological 
substrates 29, 30 and show different correlates 31, 32. So far, no study investigated 
separately the relationships of poor premorbid adjustment with the two factors of negative 
symptoms. 
While for negative symptoms the association with poor premorbid adjustment has been 
consistently reported, and further research is needed to clarify specific aspects of this 
relationship, whether positive symptoms are related with premorbid adjustment is still 
unclear as an association has been reported in some studies 33-35, but not in others 21, 36. 
The severity of neurocognitive impairment has been mainly associated with the academic 
domain of premorbid adjustment 10, 15, 20, 21, 37-39, although in some studies deficits of 
some cognitive domains, such attention and executive functions, have been found more 
closely related to the social than to the academic aspects of premorbid adjustment 40, 41. The 
specific cognitive deficits found in association with premorbid adjustment are extremely 
heterogeneous in the different studies. 
As to the association with poor functional outcome, more often premorbid adjustment has 
been associated with global functioning or with the majority of explored areas of functioning, 
whereas a consistent pattern of associations with specific areas of functioning has not been 
described 42-46. 
In the light of the strong link between premorbid adjustment and neurodevelopmental 
aspects of the disorder, as well as of the above‐reported controversial findings and open 
issues, in this study we tried to address the following questions: (i) Is the functional 
impairment observed in patients before the onset of schizophrenia also observed in their 
unaffected first‐degree relatives during early epochs of life? If yes, does it involve both 
domains of adjustment? (ii) Are distinct patterns of premorbid adjustment course (i.e. ‘stable‐
good’, ‘stable‐poor’, ‘deteriorating’) associated with the same psychopathological and 
neurocognitive domains? (iii) Is there a relationship between premorbid adjustment and 
primary negative symptoms? Is it relevant to both factors of negative symptoms (avolition 
and poor emotional expression)? (iv) Are different domains of premorbid adjustment related 
to different negative symptoms factors and/or to different cognitive domains? (v) Is 
premorbid adjustment related to positive symptoms? (vi) Do different domains of premorbid 
adjustment have a different impact on specific areas of real‐life functioning? 
Aims of the study 
This study was aimed at exploring whether academic and social functioning during early 
epochs of life are impaired in a large sample of community‐dwelling patients with 
schizophrenia, as well as in their unaffected first‐degree relatives, with respect to healthy 
controls. In the group of patients, the associations of early functioning with the two distinct 
factors of primary negative symptoms, avolition and poor emotion expression, as well with 
neurocognition, social cognition and domains of real‐life functioning were also investigated. 
Methods 
Study design 
Premorbid adjustment in the group of patients was compared to adjustment in early age 
periods (early adjustment) of a group of their unaffected first‐degree relatives and one of 
healthy controls. In the group of patients, the associations of premorbid adjustment with 
psychopathology, neurocognition, social cognition, and real‐life functioning were investigated. 
The impact of premorbid adjustment on primary negative symptoms, selected by excluding 
the confounding effect of depression and/or parkinsonism, as well as on the two distinct 
factors, avolition and poor emotional expression, was also explored. 
Subjects 
Patients were recruited among those consecutively seen at the outpatient units of 26 Italian 
university psychiatric clinics and/or mental health departments from March 2012 to 
September 2013. 
Inclusion criteria were a diagnosis of schizophrenia according to DSM‐IV, confirmed with the 
Structured Clinical Interview for DSM‐IV ‐ Patient version (SCID‐I‐P), and an age between 18 
and 66 years. Exclusion criteria were as follows: (i) history of head trauma with loss of 
consciousness; (ii) history of moderate to severe mental retardation or of neurological 
diseases; (iii) history of alcohol and/or substance abuse in the last 6 months; (iv) current 
pregnancy or lactation; (v) inability to provide an informed consent; (vi) treatment 
modifications and/or hospitalization due to symptom exacerbation in the last 3 months. 
For each recruited patient who agreed to involve relatives, two unaffected first‐degree 
relatives were recruited, when available. They were, in order of preference, the two parents, 
or one parent and one sibling, or two siblings. Healthy controls were recruited through flyers 
from the community at the same sites as the patient sample. Exclusion criteria for relatives 
and controls were the same as listed above for patients from (i) to (v), plus a current or 
lifetime Axis I or II psychiatric diagnosis, as assessed with the SCID‐I‐Non Patient version and 
the SCID‐II. 
All subjects signed a written informed consent to participate after receiving a comprehensive 
explanation of the study procedures and goals. 
Procedures 
The study has been conducted in accordance with the principles of the Declaration of Helsinki 
(59th World Medical Association General Assembly; October 2008). Approval of the study 
protocol was obtained from the Ethics Committees of the participating centers. 
Assessments 
Premorbid characteristics 
The assessment of premorbid functioning in patients, as well as of early adjustment in 
relatives and controls, was carried out using the Premorbid Adjustment Scale (PAS) 47. This 
instrument assesses five psychosocial domains (sociability and withdrawal, peer 
relationships, scholastic performance, adaptation to school, and social‐sexual functioning), 
and four age periods (childhood up to 11 years, early adolescence from 12 to 15 years, late 
adolescence from 16 to 18 years, and adulthood from 19 years on). Social‐sexual functioning 
is not measured during childhood, whereas school adaptation and school performance are not 
assessed during adulthood. A more global, ‘General’ section is included, containing items 
meant to estimate the overall functioning, for the entire period prior to the first episode, in 
nine areas (education, employment or school, change in work or school performance between 
1 year and 6 months and between 3 years and 6 months before onset, independence, highest 
level of functioning, social‐personal adjustment, degree of interest in life, and energy level). 
Ratings are made on a 0‐ to six‐point Likert scale, with 0 indicating normal adjustment and six 
indicating severe impairment. To gather information about the premorbid period, a semi‐
structured interview with the participant and her/his family members was used. The PAS 
defines as ‘premorbid’ the period ending 6 months before the first episode of illness. 
In this study, the following criteria were adopted to analyze the PAS data: (i) scores for the 
adult age period were not analyzed in order to minimize possible contamination with early 
prodromal and psychotic symptoms of the illness; (ii) as suggested by other authors 27, the 
final ‘General’ section was not analyzed, because regarded as less reliable than the others; (iii) 
according to the procedure followed in previous studies 19, 37, separate scores were 
calculated for social and academic premorbid domains of functioning at each age level, by 
averaging the items sociability, withdrawal, peer relationships, and social‐sexual functioning 
for the social domain and the items scholastic performance and adaptation to school for the 
academic domain; an academic and a social mean score were then calculated by averaging the 
scores of the considered age period for each of the two domains; (iv) as in several previous 
studies 10, 26, 27, the course of premorbid functioning was classified into three different 
patterns: deteriorating, stable‐good, and stable‐poor, according to the criteria proposed by 
Haas and Sweeney 48. The deteriorating pattern was defined as a progressive decline 
characterized by a worsening in the PAS global score (sum of scores divided by the highest 
possible score within each age period) of at least two points between childhood and 
adulthood, or a proportionate decline for cases in which illness onset was before late 
adolescence or adulthood (i.e. a change between age groups of at least 0.66). The remaining 
cases were regarded as stable, and the median value of the PAS global score (0.34 in our 
study) was used as a cutoff point to categorize the subjects as stable‐good or stable‐poor. 
Psychopathology 
The Positive and Negative Syndrome Scale (PANSS) was used to rate symptom severity. 
Scores for the dimension ‘positive symptoms’ were calculated according to Wallwork et 
al. 49by summing the scores for delusions, hallucinatory behavior, grandiosity, and unusual 
thought content. 
Negative symptoms were assessed using the Brief Negative Symptom Scale (BNSS) 50, an 
instrument designed to overcome the problem of heterogeneity of these symptoms. In fact, in 
line with previous research 50, 51, this instrument allows the identification of two separate 
factors: avolition, consisting of anhedonia, asociality and avolition, and poor emotional 
expression, including blunted affect and alogia. The Italian version of the scale was validated 
as part of the Italian Network project 52. 
The assessment of depressive and extrapyramidal symptoms was carried out to exclude that 
negative symptoms were secondary to them. The Calgary Depression Scale for Schizophrenia 
(CDSS) 53 was used to assess depressive symptoms. This includes nine items (depression, 
hopelessness, self‐depreciation, guilty ideas of reference, pathological guilt, morning 
depression, early wakening, suicide, observed depression), each rated from 0 (absent) to 3 
(severe). Ratings >6 on the total score indicate clinically significant depression 53. The St. 
Hans Rating Scale (SHRS) 54 was used to investigate the presence of extrapyramidal 
symptoms. This is a multidimensional rating scale comprising four subscales: hyperkinesia, 
parkinsonism, akathisia, and dystonia. Each subscale includes one or more items, with a score 
ranging from 0 (absent) to 6 (severe). Clinically significant extrapyramidal symptoms, which 
might confound the assessment of negative symptoms, were defined by a ‘mild’ (two) rating 
on at least three items, or a ‘mild’ rating for tremor or rigidity plus a ‘mild’ rating on at least 
another item, or a ‘mild‐moderate’ (three or more) rating on at least one item. Bradykinesia 
and reduced facial expression were not included among confounding symptoms, due to the 
high probability that their presence represents a sign of diminished expression. 
Neurocognition 
The Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) 
Consensus Cognitive Battery (MCCB) was used for neurocognitive assessment, as it is 
regarded as the ‘state‐of‐the‐art’ neuropsychological battery for research purposes in 
schizophrenia 55, 56. This battery includes tests for the assessment of six distinct cognitive 
domains: processing speed, attention/vigilance, working memory, verbal learning, visual 
learning, reasoning, and problem solving. 
Social cognition 
The assessment of social cognition, partly carried out by the MCCB Mayer‐Salovey‐Caruso 
Emotional Intelligence Test (MSCEIT) managing emotion section, was integrated by the Facial 
Emotion Identification Test (FEIT) 57, which examines emotion perception, and The 
Awareness of Social Inference Test (TASIT) 58, which is a theory of mind test consisting of 
seven scales (positive emotions, negative emotions, sincere, simple sarcasm, paradoxical 
sarcasm, enriched sarcasm, lie), organized into three sections: emotion recognition, social 
inference‐minimal, and social inference‐enriched. 
Real‐life functioning 
Real‐life functioning was assessed by means of the Specific Levels of Functioning Scale 
(SLOF) 59, 60, an instrument endorsed by the panel of experts involved in the Validation of 
Everyday Real‐World Outcomes (VALERO) initiative as a suitable measure exploring different 
domains of functioning 61, 62. The following domains, characterized by a sufficient level of 
variability, were analyzed: interpersonal relationships, community activities (e.g. shopping, 
using public transportation), and working abilities. Higher scores correspond to better 
functioning. 
Data analysis 
Co‐norming and standardization of the Italian MCCB test scores was carried out as described 
in Kern et al. 55, 63. For cognitive domains including more than one measure, that is working 
memory and speed of processing, the summary score for the domain was calculated by 
summing the scores of the tests included in that domain and then standardizing the sum to 
a T‐score. In this way, all test scores and domain scores were standardized to the same 
measurement scale with a mean of 50 and standard deviation of 10. Social cognition variables 
were standardized with respect to Italian normative data. The mean of standardized scores of 
MSCEIT, FEIT, and TASIT was used as a composite score. All the other variables were 
transformed into z‐scores. 
Differences among groups on categorical variables (gender distribution and PAS course 
categorization) were investigated by using Pearson's chi square test. 
Independent one‐way analyses of variance (ANOVAs) were used to test group differences on 
demographic variables. In case of group differences on these indices, group comparisons were 
performed by entering them as covariates. An exception was made for education, as its 
assessment is included in the PAS and there is an overlap between premorbid adjustment and 
educational level 12, 64. 
Multivariate analyses of variance (MANOVAs) were run to investigate: (i) differences on indices 
of early adjustment among patients, relatives, and controls, as well as among parents and 
siblings within the group of relatives in order to control for the possible confounding effect 
related to the older age and lower education of parents; (ii) differences between patient 
groups with different premorbid adjustment course (stable‐good, stable‐poor, and 
deteriorating) with respect to psychopathology, neurocognition, social cognition, functional 
outcome, and PAS academic and social profiles. When a group difference or an interaction 
between groups and domains was statistically significant, univariate effects were examined 
using Sheffe's post hoc test. 
To investigate the associations of premorbid adjustment with psychopathological, cognitive, 
and real‐life functioning indices, correlation analyses were carried out by means of Pearson's 
test. Furthermore, stepwise multiple regression analyses were run, in which mean scores of 
PAS academic and social domains were entered as dependent variables, whereas independent 
variables included gender, as well as psychopathological dimensions and cognitive indices 
which differed between patient subgroups with different premorbid adjustment course. 
Results 
Subjects 
The study was carried out in a large sample of community‐dwelling patients with a DSM‐IV 
diagnosis of schizophrenia (n = 915), as well as in a group of their unaffected first‐degree 
relatives (n = 368: 249 parents, 119 siblings) and one of healthy controls (n = 778) in the 
context of the multicenter study of the Italian Network for Research on Psychoses 65. Group 
comparisons on demographic variables showed a higher frequency of male gender among 
patients (69.4%) with respect to both relatives and controls (42.9% and 48.4%, 
respectively; P≤ 0.000001), an older age in relatives (55.0 ± 13.7 years) with respect to 
patients and controls (40.2 ± 10.7 and 40.5 ± 12.5 years, respectively; P ≤ 0.00002), due to the 
fact that also parents were included in the group of relatives (mean age: 61.5 ± 8.4 years for 
parents, 41.3 ± 12.6 years for siblings; P ≤ 0.000001), and a higher education level in controls 
(13.0 ± 4.0 years) than in patients and relatives (11.6 ± 3.4 and 11.3 ± 4.0 years, 
respectively; P ≤ 0.00002). In subsequent comparisons among the three groups, gender and 
age were used as covariates, whereas education was not, as reported in the Methods section. 
Comparisons on demographic variables among patients with different premorbid adjustment 
course (stable‐good, n = 329; stable‐poor, n = 329; deteriorating, n = 249) showed that age 
and gender distribution were comparable, whereas education was higher in the stable‐good 
subgroup compared with the other two. 
Group comparisons between patients, unaffected relatives, and 
healthy controls on PAS indices 
The MANOVA on PAS academic and social dimensions comparing patients, relatives, and 
controls showed a significant group effect (F2,1677 = 524.83, P ≤ 0.000001), due to a poorer 
early adjustment in patients with respect to both controls and relatives for both PAS domains 
and for all age periods (Fig. 1a). 
 
Figure 1 
 
Group comparisons on PAS Academic and Social dimensions. (a) Patients show a greater 
impairment with respect to both healthy controls and unaffected relatives for both PAS 
domains, in all age periods, as well as a highly significant worsening over time, not observed 
in the other two groups. *Statistically significant difference with respect to unaffected 
relatives and healthy controls: P < 0.000001. §Statistically significant difference with respect 
to the previous age period: P < 0.000001. (b) A greater impairment is observed, 
independently from age periods, in patients with respect to the other two groups for both 
Academic and Social PAS domain, as well as in unaffected relatives with respect to healthy 
controls only for the Academic domain. *Statistically significant difference with respect to 
unaffected relatives and healthy controls: P < 0.000001. #Statistically significant difference 
with respect to healthy controls: P < 0.01. 
Moreover, a statistically significant group‐by‐age period interaction (F4,3354 = 90.46, P ≤ 
0.000001) was observed. According to the post hoc analysis, it was due to a significant 
worsening of premorbid adjustment over time (childhood vs. early adolescence as well as 
early vs. late adolescence), independently of the PAS domain, in the group of patients, 
whereas such a progression was not observed in the other two groups (Fig. 1a). 
A significant interaction group‐by‐dimension was also observed (F2,1677 = 28.89, P ≤ 0.000001) 
that, according to post hoc analysis, was due to a greater impairment in patients with respect 
to the other two groups for both domains, and to a poorer functioning in relatives with 
respect to controls only for the academic domain, independently by the age period (Fig. 1b). 
The MANOVA on PAS academic and social dimensions comparing parents and siblings within 
the group of relatives showed no statistically significant interaction with kinship. 
The comparisons among the three groups on the frequency of different patterns of course of 
early adjustment showed that a poor early adjustment was more frequent in patients (63.7%) 
with respect to relatives and controls (9.5% and 5.4%, respectively; P ≤ 0.00001) and, to a less 
degree, in relatives with respect to controls (P ≤ 0.01). 
Comparisons among patient groups with different course of 
premorbid adjustment 
Comparisons among the three subgroups of patients with different course of premorbid 
adjustment revealed the lack of differences for all the investigated psychopathological, 
cognitive, and real‐life functioning indices between patients with the stable‐poor pattern and 
those with the deteriorating one. Therefore, these two subgroups were collapsed in a single 
class named ‘poor premorbid adjustment’ (poor‐PA, n = 578) that was compared to the 
remaining one named ‘good premorbid adjustment’ (good‐PA, n = 329). The only difference 
between the two subgroups on demographic variables was a higher level of education in the 
good‐PA with respect to the poor‐PA group. The MANOVA on psychopathological variables 
comparing poor‐PA vs. good‐PA patients showed a significant group effect (F1,905 = 33.04, P ≤ 
0.000001) and a significant group‐by‐symptom interaction (F2,1810 = 4.02, P ≤ 0.02), due to a 
greater severity of both negative symptoms subdomains (poor emotional expression and 
avolition) in the poor‐PA group (Fig. 2a). 
 
Figure 2 
 
Comparisons on psychopathological variables between patients with good premorbid 
adjustment (Good‐PA) and patients with poor premorbid adjustment (Poor‐PA). (a) In the 
whole sample of patients, both domains of negative symptoms (Poor Emotional expression 
and Avolition) are more severe in the poor‐PA group with respect to the good‐PA one. (b) 
After the exclusion of patients with clinical significant depression and/or parkinsonism, only 
Avolition is more severe in the poor‐PA group with respect to the good‐PA one. POS = positive 
symptoms; EMO‐EXPR = Reduced emotional expression; AVO = Avolition. *Statistically 
significant group difference: *P ≤ 0.003; **P ≤ 0.0005; ***P ≤ 0.00001. 
When the MANOVA was run in the subsample without clinically significant depression and/or 
parkinsonism (n = 480), significant effects of group (F1,478 = 19.32, P ≤ 0.000001) and of 
symptom subdomain (F2,956 = 4.86, P ≤ 0.01) were observed, whereas the group‐by‐symptom 
domain interaction only approached the statistical significance (F2,956 = 2.65, P ≤ 0.07). Post 
hoc analysis in this subsample revealed a statistically significant greater severity of avolition 
only in the poor‐PA group (Fig. 2b). 
The MANOVA on neurocognitive domains showed a significant effect of group (F1,860 = 16.58, P≤ 
0.00005) and domain (F5,4300 = 62.44, P ≤ 0.000001), and a significant group‐by‐domain 
interaction (F5,4300 = 2.17, P ≤ 0.05) that, according to post hoc analysis, was due to a more 
severe impairment of working memory in the poor‐PA group with respect to the good‐PA one 
(Table 1). The MANOVA on the social cognition index showed a significant effect of group 
(F1,897 = 8.15, P ≤ 0.004), due to a greater impairment in the poor‐PA group with respect to the 
good‐PA one (Table 1). 
Table 1. Comparisons on cognitive domains and areas of real life functioning between 
patients with good premorbid adjustment (good‐PA) and patients with poor premorbid 
adjustment (poor‐PA) 
 
 
 
PANSS, Positive and Negative Syndrome Scale; BNSS, Brief Negative Symptom Scale. 
Statistically significant group difference: *P ≤ 0.01; **P ≤ 0.00001. 
 
A pattern of group differences analogous to those reported above emerged by the MANOVArun 
on SLOF areas, showing a significant group effect (F1,885 = 46.29, P ≤ 0.000001) and a 
significant group‐by‐area effect (F2,1770 = 3.32, P ≤ 0.04). Post hoc analyses showed a greater 
impairment of all the considered areas of real‐life functioning in poor‐PA with respect to good 
PA (Table 1). 
Correlation analyses in the patient sample 
Results of correlation analyses are reported in Table 2. Statistically significant positive 
correlations were observed between both academic and social PAS domains and the three 
considered psychopathological indices (poor emotional expression, avolition, and positive 
symptoms; P ≤ 0.0001 for all of them), indicating that a worse premorbid adjustment is 
associated to more severe psychopathology. The association was slightly stronger for 
avolition (r = 0.16) with respect to the other two symptom dimensions (r = ≤0.13), in 
particular in the subsample of patients without clinically significant depression and/or 
parkinsonism (n = 482; r = 0.32 for avolition, r ≤ 0.26 for the remaining two dimensions). 
Table 2. Results of correlation analyses 
 
 
All neurocognitive domains, as well as the social cognition index, were negatively correlated 
with both PAS domains. These correlations indicate that a worse premorbid adjustment is 
associated to a worse neurocognitive and social cognition performance. They were 
statistically significant for all neurocognitive domains (P ≤ 0.0001 for all of them) and for 
social cognition (P ≤ 0.0001) when considering the academic PAS domain, and only for speed 
of processing, working memory, verbal learning, and reasoning and problem solving (P ≤ 
0.0001 for all of them) when considering the social PAS domain. In the subsample of patients 
without depression and/or parkinsonism, the same pattern of results was observed for the 
academic domain, whereas for the social domain the only statistically significant association 
was with working memory. 
Statistically significant negative correlations were also observed between both PAS domains 
and the three SLOF areas (P ≤ 0.0001 for all of them), indicating that a worse premorbid 
adjustment is associated to worse real‐life functioning in all the examined domains. Slightly 
stronger associations were observed between the PAS academic domain and work abilities 
(r = −0.23 vs. r ≤ −0.17), as well as between social PAS domain and interpersonal relationships 
(r = −0.27 vs. r ≤ −0.19). This pattern of correlations did not change after the exclusion of 
patients with clinically significant depression and/or parkinsonism. 
Stepwise multiple regression analyses in the patient sample 
Results of multiple regression analyses are reported in Table 3. The mean score on the PAS 
academic domain was associated with the working memory neurocognitive domain (F3,868 = 
87.8, R2 = 0.09), avolition (F3,868 = R2 = 0.01), and gender (F3,868 = 7.7, R2 = 0.008) (the worse the 
academic premorbid adjustment, the poorer the performance on the tests exploring working 
memory, the more severe the avolition, and the higher the percentage of males). The mean 
score on the PAS social domain was associated with avolition (F2,894 = 74.6, R2 = 0.08) and 
working memory (F2,894 = 17.3, R2 = 0.02) (the worse the social premorbid adjustment, the 
more severe the avolition, and the poorer the performance on working memory test). After 
excluding subjects with clinically significant depression and/or parkinsonism, the association 
between academic PAS domain and working memory, as well as that between social PAS 
domain and avolition, became slightly stronger (R2 = 0.10 for both). 
Table 3. Results of multiple regression analyses 
 
 
Discussion 
According to our findings, premorbid adjustment in patients with schizophrenia, as compared 
to early adjustment in healthy controls and patients’ unaffected first‐degree relatives, is 
poorer for both social and academic domains during childhood and early and late 
adolescence. This finding is in line with a large body of literature reporting an impairment of 
premorbid adjustment in patients with schizophrenia with respect to healthy 
controls 64, 66, 67. 
Unaffected relatives also differed from healthy controls, although to a lesser extent than 
patients, by showing a poorer early adjustment only for the academic domain and 
independently of the age period, as well as a slightly greater frequency of poor early 
adjustment. These findings, in line with those of other studies exploring early adjustment in 
patients’ relatives 4-8, 64, support the hypothesis that poor early adjustment may represent a 
marker of vulnerability to schizophrenia. 
The exclusive involvement of the academic domain in relatives, already reported by other 
authors 4, 5, could be related to a mild cognitive dysfunction that has been described by 
several authors 68-73 and found in the sample of relatives recruited in the present 
multicenter study 63, 74. 
It should be noticed that the differences in early adjustment we observed between relatives 
and controls were small, although statistically significant. An underestimation of impairment 
in early epochs of life in relatives cannot be excluded; it might be due to a retrospective recall 
bias that could be greater in this group since it includes also parents (for which a long time 
elapsed since early epochs of life and no further source of information was available). As a 
matter of fact, more marked differences were reported when the group of relatives consisted 
of offspring of patients 5. It should be acknowledged that the inclusion of parents together 
with siblings in the group of relatives represents a limitation of our study design, as it 
introduces a potential bias due to the fact that parents are older and less educated than 
siblings; therefore we controlled for this potential bias by comparing PAS severity among 
parents and siblings, and found no statistically significant interaction with kinship. 
Our data also confirm the previously reported impact of poor premorbid adjustment on 
negative symptoms 9, 11, 75 but not on the positive ones 21, 36. In this study, for the first 
time to our knowledge, the impact of premorbid dysfunction was investigated on the two 
factors of the negative psychopathological dimension, that is avolition and poor emotional 
expression. When considering the subsample of patients without clinically significant 
depression and/or parkinsonism, we found a greater severity of avolition in the poor‐PA 
group with respect to the good‐PA one, and an association of academic and social premorbid 
impairment with both negative factors. Furthermore, regression analyses revealed the lack of 
associations between the two PAS domains and the negative factor poor emotional 
expression, whereas both academic and social PAS domains were significantly associated with 
avolition; this association resulted slightly stronger with the social PAS domain, in particular 
after excluding the confounding effect of depression and/or parkinsonism. These findings are 
in line with the hypothesis that the two distinct dimensions of negative symptoms are 
subtended by different pathophysiological mechanisms and neurobiological correlates. 
According to recent literature, a key role in the pathophysiology of poor emotional expression 
seems to be played by a dysfunction of amygdala and hippocampus, known to be involved in 
emotion recognition and expression, whereas avolition has mainly been associated with 
abnormalities in prefrontal‐subcortical circuits involved in motivation and goal‐directed 
behaviour 32, 76, and is a much stronger predictor of functioning than is poor emotional 
expression 77, 78. Our finding of a stronger association of poor premorbid functioning, 
especially of its social component, with avolition than with poor emotional expression, 
suggests that the former is more likely related to neurodevelopmental abnormalities with 
respect to the latter and that such abnormalities may involve neural circuits implicated in 
goal‐oriented behavior. 
A greater impairment of working memory and social cognition was observed in patients with 
poor‐PA with respect to those with good‐PA. An association between premorbid dysfunction 
and impairment in working memory has already been reported 10, 39, whereas the 
relationship between social cognition and premorbid adjustment was explored for the first 
time in this study. Different patterns of association of poor‐PA with other neurocognitive 
domains have also been found 15, 21, 79, 80. Such discrepancies may be related to the great 
heterogeneity among different studies in the choice of the test battery and selection of 
cognitive domains. 
Regression analyses showed that working memory was more strongly associated to the PAS 
academic domain than to the social one, especially in the subsample of patients without 
clinically significant depression and/or parkinsonism, whereas avolition was more strongly 
related to the social than to the academic PAS domain. These two different patterns of 
associations have been reported in the majority of previous studies (8, 10, 15-18, 20, 21, 37), 
with some exception 23-25, 40 and are confirmed in this study when excluding the 
confounding effect of depression and/or parkinsonism. 
As to real‐life functioning, we found that all the investigated areas were more impaired in the 
group of patients with poor‐PA, and that their impairment was associated to both PAS 
domains. This confirms the impact of premorbid dysfunction on real‐life functioning, as 
reported by several authors 42-46. 
In conclusion, our findings confirm the presence of a global impairment of premorbid 
adjustment in patients and an impairment of early adjustment in patients’ unaffected first‐
degree relatives mainly involving the academic domain. Our data confirm that the two PAS 
domains show different patterns of associations, with the academic domain mainly associated 
with cognitive deficits, in particular working memory, and the social domain mostly 
associated with primary negative symptoms, in particular avolition. Instead, premorbid 
adjustment domains are not associated with the severity of positive symptoms, whereas both 
of them are associated with social cognition and real‐life functioning. 
The impairment of functioning occurring in patients before the illness onset, as well as in their 
unaffected relatives during early epochs of life, suggests that poor early adjustment may 
represent a marker of vulnerability to schizophrenia. However, the possibility that it is a 
consequence of cognitive deficits and/or avolition cannot be ruled out based on available 
findings. 
Findings from our study have some potential clinical implications. First of all, they suggest the 
inclusion of a comprehensive assessment of academic and social aspects of early functioning 
in subjects at ultra‐high‐risk for developing psychosis in algorithms implemented to predict 
psychosis. In addition, such an assessment of early functioning in these subjects, as well as its 
historical assessment in patients at their first episode of psychosis, may be informative for the 
implementation of individually tailored preventive/early intervention strategies, such as 
psychosocial and/or cognitive rehabilitation programs, based on the domain of early 
functioning resulting impaired. Early interventions on social and/or academic aspects of 
functioning may impact, respectively, the course of negative symptoms and cognitive deficits, 
which in their turn strongly influence the outcome in people with schizophrenia. 
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